A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder

NCT06673368 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped Slow enrollment

Conditions

Interventions

Sponsor

Neurocentria, Inc.